Home/Pipeline/RG003-03

RG003-03

Pandemic Flu Vaccine

PreclinicalActive

Key Facts

Indication
Pandemic Flu Vaccine
Phase
Preclinical
Status
Active
Company

About RinuaGene Biotechnology

A clinical-stage biotech developing mRNA therapeutics and vaccines with a proprietary platform, targeting HPV-related diseases, rare conditions, and infectious diseases.

View full company profile